Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
April 29, 2026
[The blind spot in oncological care; disease scenarios as a foundation for careful decision-making]
Evelien J M Kuip, Eric C T Geijteman, Hans M Westgeest
BMJ (Clinical Research Ed.)
|
March 1, 2024
Illness trajectories of incurable solid cancers
Eric C T Geijteman, Evelien J M Kuip, Jannie Oskam, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
November 29, 2017
Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasma
Peter de Bruijn, Evelien J M Kuip, Mei-Ho Lam, et al.
Plos One
|
April 7, 2026
Communication patterns in decision-making consultations between patients with advanced cancer and medical oncologists: A qualitative observational study
Daisy J M Ermers, Yvonne Engels, Henk J Schers, et al.
Journal of Pain and Symptom Management
|
November 28, 2017
Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer
Harm Westdorp, Evelien J M Kuip, Inge M van Oort, et al.
British Journal of Clinical Pharmacology
|
September 14, 2016
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients
Evelien J M Kuip, Maarten L Zandvliet, Stijn L W Koolen, et al.
JCO Clinical Cancer Informatics
|
June 30, 2025
Machine Learning-Based Prediction of Clinical Outcomes in Patients With Cancer Receiving Systemic Treatment Using Step Count Data Measured With Smartphones
Calvin G Brouwer, Branca M Bartelet, Joeri A J Douma, et al.
Palliative & Supportive Care
|
February 16, 2024
Are specialist-provided end-of-life scenarios key to initiation of advance care planning in primary care? A mixed-methods study
Sophie W Poelman, Daisy J M Ermers, Henk J Schers, et al.
European Journal of Clinical Pharmacology
|
January 15, 2016
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients
Astrid W Oosten, João A Abrantes, Siv Jönsson, et al.
Oncotarget
|
May 3, 2018
Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl
Evelien J M Kuip, Wendy H Oldenmenger, Martine F Visser-Thijs, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Nederlands Tijdschrift Voor Geneeskunde
|
April 29, 2026
[The blind spot in oncological care; disease scenarios as a foundation for careful decision-making]
Evelien J M Kuip, Eric C T Geijteman, Hans M Westgeest
BMJ (Clinical Research Ed.)
|
March 1, 2024
Illness trajectories of incurable solid cancers
Eric C T Geijteman, Evelien J M Kuip, Jannie Oskam, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
November 29, 2017
Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ß-glucuronide and morphine-6ß-glucuronide in human plasma
Peter de Bruijn, Evelien J M Kuip, Mei-Ho Lam, et al.
Plos One
|
April 7, 2026
Communication patterns in decision-making consultations between patients with advanced cancer and medical oncologists: A qualitative observational study
Daisy J M Ermers, Yvonne Engels, Henk J Schers, et al.
Journal of Pain and Symptom Management
|
November 28, 2017
Difficulties in Pain Management Using Oxycodone and Fentanyl in Enzalutamide-Treated Patients With Advanced Prostate Cancer
Harm Westdorp, Evelien J M Kuip, Inge M van Oort, et al.
British Journal of Clinical Pharmacology
|
September 14, 2016
A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients
Evelien J M Kuip, Maarten L Zandvliet, Stijn L W Koolen, et al.
JCO Clinical Cancer Informatics
|
June 30, 2025
Machine Learning-Based Prediction of Clinical Outcomes in Patients With Cancer Receiving Systemic Treatment Using Step Count Data Measured With Smartphones
Calvin G Brouwer, Branca M Bartelet, Joeri A J Douma, et al.
Palliative & Supportive Care
|
February 16, 2024
Are specialist-provided end-of-life scenarios key to initiation of advance care planning in primary care? A mixed-methods study
Sophie W Poelman, Daisy J M Ermers, Henk J Schers, et al.
European Journal of Clinical Pharmacology
|
January 15, 2016
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients
Astrid W Oosten, João A Abrantes, Siv Jönsson, et al.
Oncotarget
|
May 3, 2018
Influence of aprepitant and localization of the patch on fentanyl exposure in patients with cancer using transdermal fentanyl
Evelien J M Kuip, Wendy H Oldenmenger, Martine F Visser-Thijs, et al.
Page
of 3